Awareness, treatment and control of hyperlipidaemia, hypertension and diabetes mellitus in a selected population of southern Italy

European Journal of Epidemiology

Volumn 13, Issue 4, 1997, Pages 421-428

  Gnasso, A ^a,b   Calindro, M C ^a   Carallo, C ^a   De Novara, G ^a   Ferraro, M ^a   Gorgone, G ^a   Irace, C ^a   Romeo, P ^a   Siclari, D ^a   Spagnuolo, V ^a   Talarico, R ^a   Mattioli, P L ^a   Pujia, A ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b Policlinico Mater Domini   (Italy)

Author keywords

Atherosclerosis; Awareness; Diabetes Mellitus; Hyperlipidaemia; Hypertension

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DISEASE CONTROL; FEMALE; HEALTH EDUCATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE;

ADULT; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; ITALY; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 8544255516     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007369203648     Document Type: Article

References (25)

1. Brand FN, Smith RT, Brand PA. Effect of economic barriers to medical care on patients' noncompliance. Public Health Rep 1977; 92: 72-78.
2. Burke GL, Sprafka JM, Folsom AR, Luepker RV, Norsted SW, Blackburn H. Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986: The Minnesota heart survey. Int J Epidemiol 1989; 18 (suppl 1): S73-S81.
3. Clearfield MB, Fedorko S, McKinney ME. Physician awareness of elevated cholesterol. J Am Osteopath Assoc 1990; 90: 139-144.
4. Greenland P, Hildreth NG, Maiman LA. Attendance patterns and characteristics of participants in public cholesterol screening. Am J Prev Med 1992; 8: 159-164.
5. Heath GW, Vartiainen E, Wheeler FC. Self-reported frequency of serum cholesterol testing, awareness of test results, and laboratory cholesterol values in two South Carolina communities. Public Health Rep 1993; 108: 465-470.
6. International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: Scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992; 2: 113-156.
7. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: The national health and nutrition examination surveys. JAMA 1993; 269: 3002-3008.
8. Kasl SV. Social and psychological factors in the etiology of coronary heart disease in black populations: An exploration of research needs. Am Heart J 1984; 108: 660-669.
9. Marmot M. Coronary heart disease: rise and fall of a modern epidemic. In: Marmot M, Elliott P (eds), Coronary heart disease epidemiology: From Aetiology to public health. Oxford: Oxford University Press, 1992: 3-19.
10. McGovern PG, Burke GL, Sprafka JM, Xue S, Folsom AR, Blackburn H. Trends in mortality, morbidity, and risk factor levels for stroke from 1980 through 1990: The Minnesota heart survey. JAMA 1992; 268: 753-759.
11. Nieto FJ, Alonso J, Chambless LE, et al. Population awareness and control of hypertension and hypercholesterolemia. Arch Intern Med 1995; 155: 677-684.
12. Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke 1991; 22: 1485-1490.
13. Pappac G, Gergen RJ, Carroll M. Hypertension prevalence and the status of awareness, treatment, and control in the Hispanic health and nutrition examination survey (HHANES), 1982-1984. Am J Publ Health 1990; 80: 1431-1436.
14. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest-pain and intermittent claudication. Br J Prevent Soc Med 1997; 31: 42-48.
15. Salomaa V, Korhonen HJ, Tuomilehto J, et al. Serum cholesterol distribution, measurement frequency and cholesterol awareness in three geographical areas of Finland. Eur Heart J 1990; 11: 294-301.
16. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992; 327: 776-781.
17. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Publ Health 1992; 82: 1607-1612.
18. Shulman NB, Martinez B, Brogan D, et al. Financial costs as an obstacle to hypertension therapy. Am J Publ Health 1986; 76: 1105-1108.
19. Snedecor GW, Cochran WG. Statistical methods, 8th edn. Ames, 1A: Iowa State University Press.
20. Spencer MP. Frequency spectrum analysis in Doppler diagnosis. In: Zwiebel WJ (ed), Introduction to vascular ultrasonography. New York: Grune & Stratton, 1986: 53-80.
21. Sprafka JM, Folsom AR, Burke GL, Edlavitch SA. Prevalence of cardiovascular disease risk factors in blacks and whites: The Minnesota heart survey. Am J Publ Health 1988; 78: 1548-1549.
22. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Publ Health 1994; 84: 1768-1774.
23. Strandness DE. Non-invasive evaluation of arteriosclerosis: Comparison of methods. Arteriosclerosis 1983; 3: 103-116.
24. Study Group, European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 1987; 8: 77-88.
25. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham heart study. N Engl J Med 1990; 322: 1635-1641.